insight
show solid momentum increment improv sever
book adj ebitda margin left perhap one
metric advanc ntm backlog might round
also might manag justif conserv look
rais estim pt
 analyt ta gain traction observ technolog
incumb difficult unseat histor clintech perhap chang
difficult commerci long clinic trial durat necessarili
protract convers cycl event oce appear make commend
progress cdo growth ta increas moder vs segment
impress book traction ttm book book-to-bil jump
continu steadi climb concur book-to-bil basi
pass-through cost slightli higher percent book recogn revenu
posit indic full-servic work addit quarter manag
point higher as-award win as-contract win lead
risk contract context patient enrol common sourc delay clinic
trial driver chang order contract month recruit staff assign
studi month cost inaccur feasibl up-front reason patient
enrol meet timelin reason certainli factor think
will take risk around factor influenc feasibl site select patient
recruit data/analyt platform though absolut fix price
entir contract still would need regulatori client strategi chang also
futur risk-contracting/margin opportun also see opportun
fold pass-through cost risk pictur chang client view optim
site choos quality/spe factor could fold cost equat
forc cost revenu line thu forc manag team better
forecast could evolv margin posit margin iqv/cro
valuat pt increas reflect increas ep estim well increas
pleas see analyst certif import disclosur inform inform regard statu non-u analyst page report
chart summari quintil result
compani data streetaccount consensu jefferi llc
page
pleas see import disclosur inform page report
earn summarysourc compani file jefferi llcreport bmofi end decemb thousand except servic oper adjust net interest expens incom pre-tax incom incom unconsolid affiliates- na na loss non-controlling interest/minor non-gaap net non-gaap dilut share common size bp bp gross bp bp oper bp bpsadjust bp bpsnet interest bpsother expens incom bp pre-tax bp bpsincom bp bpsincom unconsolid bpsloss non-controlling bp bp non-gaap net bp bpssegmentstechnolog analyt solut fka commerci solut acquir organ total bp bpsr solutionsacquir organ total bp bp contract sale medic solut fka integr engag servic acquir revenue- organ total bp bp bp bookingsttm net new busi ttm quarterli quarterli jefupd guid consensusservic guidanc changereporteddifferenceiqvia hold
page
pleas see import disclosur inform page report
ia holdingsincom statementdecemb fiscal except incom servic yoy oper adjust yoy interest expens incom pre-tax incom incom unconsolid loss non-controlling interest/minor non-gaap net non-gaap yoy share common size gross oper interest expens incom pre-tax non-gaap net yoy total servic oper interest expens incom pre-tax non-gaap net compani data jefferi llc
iqvia provid biopharmaceut develop commerci outsourc inform servic technolog tool truli global basi
oper countri america europ africa asia-pacif compani primarili serv biopharmaceut
compani well healthcar compani found base durham north carolina
pt reflect multipl ep risk includ integr technolog integr synergi realiz contract
cancel book volatil fx
david windley cfa certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat specif
recommend view express research report
case jefferi employe analyst respons coverag financi instrument discuss report receiv
compens base part overal perform firm includ invest bank incom seek updat research
appropri variou regul may prevent us asid certain industri report publish period basi larg major
report publish irregular interv appropri analyst judgement
articl articl
explan jefferi rate
buy describ secur expect provid total return price appreci plu yield within period
hold describ secur expect provid total return price appreci plu yield plu minu within period
under-perform describ secur expect provid total return price appreci plu yield minu less within
expect total return price appreci plu yield buy rate secur averag secur price consist
within period compani typic volatil overal stock market hold rate secur averag
secur price consist expect total return price appreci plu yield plu minu within period
under-perform rate secur averag secur price consist expect total return price appreci plu yield minu
less within period
nr invest rate price target temporarili suspend suspens complianc applic regul and/
jefferi polici
cs coverag suspend jefferi suspend coverag compani
nc cover jefferi cover compani
restrict describ issuer conjunct jefferi engag certain transact compani polici applic secur
regul prohibit certain type commun includ invest recommend
monitor describ secur whose compani fundament financi monitor financi project opinion
invest merit compani provid
jefferi methodolog assign rate may includ follow market capit matur growth/valu volatil expect total
return next month price target base sever methodolog may includ restrict analys market
p/fcf premium discount /averag group ev/ebitda premium discount /averag group price-to-earnings sum part net asset valu dividend return
return equiti roe next month
jefferi franchis pick includ stock select among best stock idea equiti analyst month period stock select
base fundament analysi may take account factor analyst convict differenti analysi favor risk/reward
ratio invest theme jefferi analyst recommend jefferi franchis pick includ buy rate stock number
vari depend analyst recommend inclus stock ad new opportun aris remov reason
inclus chang stock met desir return longer rate buy and/or trigger stop loss stock day volatil
bottom quartil stock continu stop loss remaind stop franchis pick intend
page
pleas see import disclosur inform page report
